|  | Co | P3 | P30 | Ca | CaP3 | CaP30 |
---|---|---|---|---|---|---|---|
 |  | Inflammation | |||||
Incidence (%) | ♀ | 12.5 | 25.0 | 25.0 | 0 | 0 | 0 |
♂ | 25.0 | 50.0 | 25.0 | 0 | 13.0 | 0 | |
Multiplicity (mean ± SD) | ♀ | 0.037 ± 0.1 | 0.061 ± 0.1 | 0.082 ± 0.1 | 0 | 0 | 0 |
♂ | 0.227 ± 0.4 | 0.435 ± 0.6 | 0.220 ± 0.4 | 0 | 0.041 ± 0.1 | 0 | |
 |  | Morphological alterations | |||||
Incidence (%) | ♀ | 62.5 | 75.0 | 12.5 | 0 | 62.5 | 0 |
♂ | 12.5 | 50.0 | 12.5 | 0 | 0 | 0 | |
Multiplicity (mean ± SD) | ♀ | 0.310 ± 0.3a,b | 1.333 ± 1.7a | 0.082 ± 0.2a,b | 0b | 0.405 ± 0.5a,b | 0b |
♂ | 0.020 ± 0.05a,b | 1.040 ± 1.8a | 0.020 ± 0.05a,b | 0b | 0b | 0b |